𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Summary of the first 100 patients seen at a Lyme disease referral center

✍ Scribed by Leonard H. Sigal


Book ID
115683256
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
576 KB
Volume
88
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Predictors of adalimumab dose escalation
✍ Russell D. Cohen; Jeffrey R. Lewis; Hannah Turner; Laura E. Harrell; Stephen B. πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 167 KB πŸ‘ 2 views

Background: Pivotal trials for adalimumab (ADA) demonstrated effectiveness versus placebo for induction and maintenance of remission in moderate to severely active Crohn's disease (CD). Although the approved maintenance regimen in the U.S. is 40 mg subcutaneously every 14 days, some patients require